Erwinaze
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $524,274 | 455 | 183 |
| 2017 | $378,996 | 650 | 245 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $308,300 | 112 | 34.1% |
| Unspecified | $180,658 | 6 | 20.0% |
| Grant | $157,460 | 5 | 17.4% |
| Consulting Fee | $93,780 | 28 | 10.4% |
| Travel and Lodging | $77,938 | 252 | 8.6% |
| Space rental or facility fees (teaching hospital only) | $50,000 | 1 | 5.5% |
| Food and Beverage | $34,946 | 699 | 3.9% |
| Education | $188.30 | 2 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Combination treatment strategies with L-asparaginase to exploit cancer cell dependence on asparagine | Jazz Pharmaceuticals Inc. | $87,731 | 0 |
| An Open-Label, Single-Arm Pharmacokinetic Study of Intravenous Erwinaze asparaginase Erwiniachrysanthemi for the Treatment of Adult Patients with Acute Myeloid Leukemia AML with orwithout Isocitrate Dehydrogenase IDH Mutations | Jazz Pharmaceuticals Inc. | $81,297 | 0 |
| Testing the Synergistic Potential of Erwinaze to Enhance the Effect of Chemotherapy on Brain Tumors | Jazz Pharmaceuticals Inc. | $11,630 | 0 |
Top Doctors Receiving Payments for Erwinaze — Page 4
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Pediatric Hematology-Oncology | Houston, TX | $122.08 | 1 |
| , M.D | Pediatric Hematology-Oncology | Albuquerque, NM | $121.86 | 1 |
| , M.D | Pediatric Hematology-Oncology | New York, NY | $120.53 | 1 |
| , M.D | Hematology & Oncology | Charlottesville, VA | $119.82 | 1 |
| , M.D | Internal Medicine | Houston, TX | $117.71 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Pasadena, TX | $117.71 | 1 |
| , M.D | Internal Medicine | San Jose, CA | $116.97 | 1 |
| , MD | Pediatric Hematology-Oncology | Dallas, TX | $114.49 | 2 |
| , M.D | Pediatrics | Houston, TX | $112.43 | 1 |
| , M.D | Pediatric Hematology-Oncology | Greenville, SC | $112.25 | 1 |
| , MD | Pediatrics | Charlotte, NC | $112.13 | 1 |
| , M.D | Internal Medicine | Providence, RI | $111.56 | 1 |
| , M.D | Pediatrics | Cincinnati, OH | $110.62 | 1 |
| , M.D | Pediatric Hematology-Oncology | Wilkes Barre, PA | $109.83 | 1 |
| , M.D. PHD | Pediatrics | Houston, TX | $109.83 | 1 |
| , M.B.B.S | Pediatric Hematology-Oncology | Cleveland, MS | $109.83 | 1 |
| , MD | Pediatric Hematology-Oncology | Staten Island, NY | $109.83 | 1 |
| , M.D | Pediatric Hematology-Oncology | Baltimore, MD | $109.83 | 1 |
| , M.D | Pediatric Hematology-Oncology | Burlington, VT | $109.83 | 1 |
| , MD | Pediatrics | Charleston, SC | $109.83 | 1 |
| , MD | Pediatric Hematology-Oncology | Oakland, CA | $109.83 | 1 |
| , DO | Pediatrics | York, PA | $109.83 | 1 |
| , MD | Hospitalist | New Hyde Park, NY | $109.83 | 1 |
| , MD | Pediatrics | Leawood, KS | $109.83 | 1 |
| , MD | Pediatric Hematology-Oncology | New Brunswick, NJ | $109.83 | 1 |
Manufacturing Companies
- Jazz Pharmaceuticals Inc. $903,271
Product Information
- Type Drug
- Total Payments $903,271
- Total Doctors 359
- Transactions 1,105
About Erwinaze
Erwinaze is a drug associated with $903,271 in payments to 359 healthcare providers, recorded across 1,105 transactions in the CMS Open Payments database. The primary manufacturer is Jazz Pharmaceuticals Inc..
Payment data is available from 2017 to 2018. In 2018, $524,274 was paid across 455 transactions to 183 doctors.
The most common payment nature for Erwinaze is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($308,300, 34.1% of total).
Erwinaze is associated with 3 research studies, including "Combination treatment strategies with L-asparaginase to exploit cancer cell dependence on asparagine" ($87,731).